Gerold Schuler
Impact in
- Immunology top 0.01%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Dermatology top 0.1%
- Dermatology and Skin Diseases
Papers in
- Immunology 201
- Immunotherapy and Immune Responses 171
- T-cell and B-cell Immunology 32
- Psoriasis: Treatment and Pathogenesis 9
- Oncology 90
- Cancer Immunotherapy and Biomarkers 35
- Cutaneous Melanoma Detection and Management 32
- CAR-T cell therapy research 17
- Co-authors
- Nikolaus Romani (63 shared papers)Ralph M. Steinman (23 shared papers)Manfred Bernhard Lutz (22 shared papers)Franz Koch (26 shared papers)Eckhart Kämpgen (33 shared papers)Susanne Rößner (14 shared papers)Beatrice Schuler‐Thurner (49 shared papers)Alexander Enk (9 shared papers)
- Journals
- Journal of Investigative Dermatology (33 papers)The Journal of Experimental Medicine (23 papers)The Journal of Immunology (22 papers)British Journal of Dermatology (14 papers)Journal of Immunological Methods (13 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Gerold Schuler
381 papers receiving 36.1k citations
Gerold Schuler's Hit Papers
Peers
Comparison fields: 5 of 150
- Immunology 21.4k
- Dermatology 2.1k
- Oncology 5.6k
- Virology 1.1k
- Immunology and Allergy 557
Countries citing papers authored by Gerold Schuler
This map shows the geographic impact of Gerold Schuler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerold Schuler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerold Schuler more than expected).
Fields of papers citing papers by Gerold Schuler
This network shows the impact of papers produced by Gerold Schuler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerold Schuler. The network helps show where Gerold Schuler may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerold Schuler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 396 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow Hit paper breakdown → | 1999 | 2686 |
| 2 | Proliferating dendritic cell progenitors in human blood. Hit paper breakdown → | 1994 | 1609 |
| 3 | Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells Hit paper breakdown → | 2000 | 1300 |
| 4 | Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Hit paper breakdown → | 2002 | 1135 |
| 5 | Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma Hit paper breakdown → | 1999 | 1046 |
| 6 | Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicability Hit paper breakdown → | 1996 | 975 |
| 7 | Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood Hit paper breakdown → | 2001 | 967 |
| 8 | Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. Hit paper breakdown → | 1985 | 963 |
| 9 | High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. Hit paper breakdown → | 1996 | 823 |
| 10 | 1996 | 594 | |
| 11 | 1996 | 594 | |
| 12 | Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy Hit paper breakdown → | 2016 | 555 |
| 13 | 2003 | 520 | |
| 14 | 1988 | 490 | |
| 15 | 2001 | 486 | |
| 16 | Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy Hit paper breakdown → | 2016 | 484 |
| 17 | 1987 | 459 | |
| 18 | 1994 | 440 | |
| 19 | 1999 | 431 | |
| 20 | 1999 | 430 |
About Gerold Schuler
Gerold Schuler is a scholar working on Immunology, Oncology, Dermatology, Cell Biology and Pathology and Forensic Medicine, having authored 396 papers that have together received 37.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (171 papers), Cancer Immunotherapy and Biomarkers (35 papers), T-cell and B-cell Immunology (32 papers), Cutaneous Melanoma Detection and Management (32 papers), Autoimmune Bullous Skin Diseases (18 papers), CAR-T cell therapy research (17 papers), Dermatology and Skin Diseases (12 papers) and Psoriasis: Treatment and Pathogenesis (9 papers). The work is most often cited by research in Immunology (21.4k citations), Dermatology (2.1k citations), Oncology (5.6k citations), Virology (1.1k citations) and Immunology and Allergy (557 citations). Gerold Schuler has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Nikolaus Romani, Ralph M. Steinman, Manfred Bernhard Lutz, Franz Koch, Eckhart Kämpgen, Susanne Rößner, Beatrice Schuler‐Thurner, Alexander Enk, Nicole A. Kukutsch and Detlef Dieckmann. Their work appears in journals such as Journal of Investigative Dermatology, The Journal of Experimental Medicine, The Journal of Immunology, British Journal of Dermatology and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.